It has come to our notice that certain fraudulent individuals or entities are misusing our Company’s name and TCI’s registered trademarks by promoting and offering regulated and hazardous chemical substances through online platforms like YouTube. We hereby categorically clarify that TCI has no association or connection whatsoever with the products being displayed or sold in the videos. These products have been falsely represented as being associated with TCI, and the unauthorized use of our trademark and brand name is both illegal and misleading. TCI Chemicals markets and sells its products exclusively through its official website and authorized distributors. If you become aware of any such fraudulent activity or require clarification, you may reach out to us at: Sales-IN@TCIchemicals.com. Click Here to View the Caution Notice.
Product Document Searching Made Easy by 2D Code! | [Product Highlights] Endogenous Biotin-Blocking Reagent...Maximum quantity allowed is 999
CAS RN: 145821-59-6 | Product Number: T3165
Tiagabine Hydrochloride

Purity: >99.0%(HPLC)
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
50MG |
₹4,600.00
|
1 | Contact Us |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | T3165 |
Purity / Analysis Method | >99.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__0H__2__5NO__2S__2·HCl = 412.00 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
CAS RN | 145821-59-6 |
Related CAS RN | 115103-54-3 |
Reaxys Registry Number | 6378452 |
PubChem Substance ID | 253662389 |
Merck Index (14) | 9417 |
MDL Number | MFCD07369025 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 99.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 189.0 to 194.0 °C |
Specific rotation [a]20/D | -9.0 to -12.0 deg(C=1, H2O) |
Melting Point | 193 °C |
Specific Rotation | -11° (C=1.0,H2O) |
Solubility in water | Soluble |
RTECS# | TM6128245 |
References
- The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an anticonvulsant drug candidate
- Tiagabine, SK and F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1
- Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception
- Basic mechanisms of gabitril (tiagabine) and future potential developments (a review)
- Tiagabine (a review: development, mechanism of action, clinical pharmacokinetics, efficacy, adverse effects, drug interactions, clinical uses, and therapeutic potential.)
- Drug interactions involving the new second- and third-generation antiepileptic drugs
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.